Call Us for Support
+91 9654860915
Patients come to Mumbai from across Maharashtra and western India for cancer and rare-disease care. Yet sometimes a doctor here prescribes a medicine that no chemist can supply, because it is approved abroad but not launched in India.
There is still a legal route. Under the Named Patient Program, the medicine is imported for that one patient against the doctor's prescription. With 30+ years of named patient leadership, we handle the paperwork, sourcing and cold-chain delivery across Mumbai, Thane and Navi Mumbai.
Prescription-based import
Supplied on a named patient basis against your doctor's prescription.
Temperature-controlled shipping
Cold-chain packing for medicines that must stay refrigerated.
Delivery to Mumbai
Usually 7–15 days, depending on documents and logistics.
Authorised sourcing
Medicines sourced through authorised channels, in line with Indian import rules.
Only Uttar Pradesh has a higher estimated number of new cancer cases than Maharashtra among India's 38 states and union territories. The figures below come from the Indian Council of Medical Research's National Cancer Registry Programme:
| Year | Estimated new cancer cases in Maharashtra | Estimated new cancer cases in India |
|---|---|---|
| 2021 | 1,18,906 | 14,26,447 |
| 2022 | 1,21,717 | 14,61,427 |
| 2023 | 1,24,584 | 14,96,972 |
| 2024 | 1,27,512 | 15,33,055 |
| 2025 | 1,30,465 | 15,69,793 |
Source: Lok Sabha Unstarred Question No. 931, answered on 24 July 2026 (ICMR–NCRP estimates, all cancer sites, both sexes).
Maharashtra's estimate rose by roughly 9.7% between 2021 and 2025, to about 357 new diagnoses every day. The state now accounts for around 8.3% of all new cancer cases in India. Most of these patients are treated with medicines already sold here. A smaller group, often people with advanced disease or a specific genetic marker, may be prescribed a newer targeted therapy that India does not have yet.
Many families first hear about the problem at the pharmacy counter. Before you start searching, check three things with the treating doctor:
If the doctor confirms that the prescribed medicine is needed and it is not sold here, named patient import can be considered. Our Named Patient Program page explains how such programmes work worldwide.
Some companies run early access or compassionate use programmes for particular medicines. Eligibility is set by the manufacturer, and your doctor can ask whether one exists.
A trial may offer access to a newer therapy under strict protocols. Trials running in India are listed on the Clinical Trials Registry – India (CTRI).
It is not, when done properly. Import for an individual patient is provided for under the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945, with oversight by CDSCO. Our guide to import regulations for patient-specific medicines sets out the framework.
No. A valid prescription from the treating doctor is essential, and the medicine is supplied only in the prescribed quantity for the named patient.
It cannot. It is for the named patient only and is not for commercial distribution.
We work with patients, caregivers, treating doctors and hospitals. More about our team is on the About Us page.
Send the prescription along with a short note on the diagnosis. Our prescription guidelines list everything it should show.
We go through the prescription and supporting reports and let you know straight away if anything more is required.
You receive the price and the expected delivery date in writing before anything is ordered.
After you confirm, the medicine is sourced through authorised channels, imported for the named patient and delivered, usually within 7 to 15 days. A tracking number is shared after dispatch.
Mumbai's southwest monsoon, roughly June to September, brings some of the heaviest rainfall of any Indian metro, and waterlogging can slow road transport. The medicine's needs stay the same: injectable cancer therapies such as Trodelvy and Elahere must be kept at 2–8°C until use.
We ship in three temperature bands: ambient (15–25°C), refrigerated (2–8°C) and frozen (-20°C), with 24/7 temperature monitoring and WHO GDP-aligned handling. Read more about our temperature-controlled shipping.
Specialty and life-saving medicines that patients in Mumbai can access through the Named Patient Program. Open a medicine to see its uses, storage and how to request it.
Sacituzumab govitecan
Oncology
View details →
Mirvetuximab soravtansine-gynx
Oncology
View details →
Capivasertib
Oncology
View details →
Tarlatamab-dlle
Oncology
View details →
Datopotamab deruxtecan-dlnk
Oncology
View details →
Belzutifan
Oncology
View details →
Fruquintinib
Oncology
View details →
Sotorasib
Oncology
View details →
Futibatinib
Oncology
View details →
Encorafenib
Oncology
View details →
Blinatumomab
Hematology
View details →
Glofitamab-gxbm
Hematology
View details →
Fruquintinib
Oncology
View details →
Mitotane
Oncology
View details →
Defibrotide sodium
Hematology
View details →
Anakinra
Immunology
View details →
Mecasermin
Endocrinology
View details →
Cefiderocol
Other Therapeutic Areas
View details →Looking for a different medicine? Browse all medicines or ask our team.
A simple, compliant process from your doctor's prescription to delivery.
Share your enquiry and your doctor's prescription.
Our team checks the documents for authenticity and compliance.
You receive treatment details, pricing and delivery timelines.
The medicine is imported under Indian import rules and delivered to you.
Talk to our specialists. We guide patients, families and doctors through every step.